var data={"title":"Oral mucosal barrier gel: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Oral mucosal barrier gel: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/378370?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=oral-mucosal-barrier-gel-patient-drug-information\" class=\"drug drug_patient\">see &quot;Oral mucosal barrier gel: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7290545\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Episil;</li>\n      <li>Gelclair;</li>\n      <li>Mucotrol;</li>\n      <li>MuGard;</li>\n      <li>Orafate;</li>\n      <li>ProThelial</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7303413\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Gastrointestinal Agent, Miscellaneous</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7303465\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Mucosal protection:</b> Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Episil: Apply 1 to 3 pumps to the oral cavity 2 to 3 times daily, or as needed; maximum duration for continuous use: 30 days</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gelclair: Rinse, gargle, and spit 15 mL (1 single-use packet) mixed in water 3 times daily, or as needed.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Mucotrol: Slowly dissolve 1 wafer by swishing around in the mouth, 3 times daily, or as needed</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">MuGard: Rinse with 5 mL 4 to 6 times daily (for oral mucositis/stomatitis) or 4 to 6 times daily or as needed (for other ulcerative conditions); may use up to 10 mL if needed to fully coat inside of mouth</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Orafate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Oral inflammation: Brush 1.25 to 2.5 mL across the front and back of gingiva 2 times daily for the first day then once daily at bedtime until healed (maximum: 10 mL per 24 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Following dental cleaning (scaling/root planing): Brush 1.25 to 2.5 mL into gingival area daily for 4 weeks as directed (maximum: 10 mL per 24 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Following tooth extraction or gingival (gum) surgery: Place 1.25 to 2.5 mL into wound 3 times daily the first day, then twice daily or as instructed until healed (maximum: 10 mL per 24 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Following tonsillectomy or other oral soft tissue surgery: Place 2.5 to 5 mL into wound 3 times daily on the first day then twice daily or as directed (maximum: 10 mL per 24 hours) </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">ProThelial: Usual dosage: 2.5 to 5 mL every 8 hours on the first day; 2.5 to 5 mL every 12 hours thereafter (maximum: 40 mL daily) </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Prevention of chemo-radiation mucositis (beginning the first day of cancer treatment): </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Grade 1 or 2: 2.5 to 5 mL 3 times a day for 1 day, followed by 2.5 to 5 mL twice daily until 1 week after completion of chemo-radiation therapy</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Grade 3 or 4: 10 mL 3 times a day, continue until 1 week after completion of chemo-radiation therapy</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Treatment of chemo-radiation mucositis: </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Grade 1 or 2: 2.5 to 5 mL 3 times a day for 1 day, followed by 2.5 to 5 mL twice daily until 1 week after completion of chemo-radiation therapy</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Grade 3 or 4: 10 mL 3 times a day for 2 days, followed by 5 to 10 mL twice daily until 1 week after completion of chemo-radiation therapy </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46105135\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Mucosal protection:</b> Children &ge;12 years and Adolescents: Oral: Orafate: Refer to adult Orafate dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7303466\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7303470\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gel, Mouth/Throat: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Gelclair: 15 mL/packet (15 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Liquid, Mouth/Throat: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Episil:  (10 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">MuGard:  (5 mL, 240 mL) [contains benzyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Paste, Mouth/Throat: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Orafate: 10% (30 mL) [contains methylparaben, propylparaben, saccharin sodium; strawberry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">ProThelial: 10% (125 mL, 250 mL, 500 mL) [contains methylparaben, propylparaben, saccharin sodium]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Wafer, Mouth/Throat: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Mucotrol:  (21 ea, 45 ea) [sugar free; mild licorice flavor]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F20452770\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46105136\" class=\"block dosfc drugH1Div\"><span class=\"drugH1\">Dosage Forms Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Orafate and ProThelial each contain sucralfate (as a 10% paste). </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7303467\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Episil: Remove protective cap from pump and prime pump by pumping into a paper cloth until an even liquid stream develops; firmly press pump (1 to 3 times) to apply liquid stream to oral cavity, distribute to affected areas of mouth and wait for gel and protective film to form. Do not swallow. Wait 5 minutes after use before eating and drinking. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gelclair: Use before meals or as directed. Add 15 mL (1 single use packet) to water and stir (refer to product information for details); rinse around the mouth for a minimum of 1 minute (as long as possible) to coat the tongue, palate, throat, inside of cheeks, and all oral tissue thoroughly. Mixture should be gargled and spit out. Avoid eating or drinking for at least 30 to 60 minutes following treatment. If water is not available, may use undiluted. If unable to rinse and gargle, apply directly to mouth using a sponge or swab. No adverse effects are anticipated is accidently swallowed. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Mucotrol: Wafer should be swished around the mouth and allowed to slowly dissolve. Avoid eating or drinking for at least 1 hour following treatment. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">MuGard: Gently pour 5 mL into mouth and rinse entire oral cavity for at least 1 minute (if rinsing is painful, spread throughout mouth by gently rotating head). Ensure all parts of the oral cavity are coated; may use up to 10 mL to coat entire oral cavity if needed. May spit or swallow excess rinse. Avoid eating or drinking for at least 1 hour following treatment. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Orafate: Apply in any of the following ways: either brushed alone or with toothpaste over affected tooth-gum line area for 2 minutes with an up and down motion; mix with equal portions of dentifrice (tooth paste, powder, gel) and layer over areas of soft tissue adjacent to teeth cleaned by the dental clinician; dab directly on to affected gum margin (allow to sit 2 minutes, then gargle and spit); layer onto affected oral area (allow to sit 2 minutes, then remove manually or spit); or place in mouth and suck back and forth through spaces between teeth. Safe if swallowed. Avoid eating or drinking for at least 1 hour following use. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">ProThelial: Scoop paste from jar and place in mouth for 30 seconds. Use tongue or cotton-tipped swab to apply paste throughout oral mucosa. Can be swished and then expectorated or swallowed. May be mixed (1:1) with yogurt, pudding, apple sauce, tapioca, or ice cream to improve taste. Avoid eating or drinking for at least 1 hour following use.  </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7303414\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Mucosal protection:</b> Management of oral mucosal pain and protection from further irritation caused by oral mucositis/stomatitis (resulting from chemotherapy or radiation therapy); irritation;  lesions, periodontal and gingival inflammation, tooth extractions, and wounds/lesions due to oral surgery; chafing; minor lesions; traumatic ulcers, and abrasions caused by braces/ill-fitting dentures or disease; diffuse aphthous ulcers (canker sores).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7303418\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">&lt;1%, postmarketing, and/or case reports: Burning sensation of mouth, mild stinging sensation (oral cavity), oral inflammation (mild)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7303415\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hypersensitivity to any ingredient or component of the formulation</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Additional product-specific contraindications: Episil: Hypersensitivity to peanuts, soya, or peppermint oil</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7303416\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concurrent drug therapy related issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Sublingual medications: May decrease absorption of sublingually administered medications.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Episil: Contains alcohol (may cause irritation when applied), propylene glycol (may cause skin irritation), soy, and peppermint oil (may cause allergic reaction).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Gelclair: Avoid eating or drinking for at least 30 to 60 minutes following use.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Mucotrol, MuGard, Orafate, ProThelial: Avoid eating or drinking for at least 1 hour following use.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Orafate, ProThelial: Safe if swallowed; however, evaluate swallowing capability prior to use to minimize incidental ingestion. May cause constipation if swallowed.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: Consult a health care provider if no improvement is seen after 7 days of use.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16061134\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16061132\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=9507&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7303469\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Monitor mucositis/stomatitis symptoms/severity</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7303563\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Adheres to the mucosal surface of mouth forming a protective film or coating over the irritated areas and lesions, protecting the lesion from further irritation and pain.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23613343\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Paste</b> (Orafate Mouth/Throat)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10% (30 mL): $453.93</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Paste</b> (ProThelial Mouth/Throat)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10% (250 mL): $2383.67</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>The pricing data provide a representative AWP and/or AAWP price from a single manufacturer of the brand and/or generic product, respectively. The pricing data should be used for benchmarking purposes only, and as such should not be used to set or adjudicate any prices for reimbursement or purchasing functions. Pricing data is updated monthly.</p></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Barber C, Powell R, Ellis A, et al, &ldquo;Comparing Pain Control and Ability to Eat and Drink With Standard Therapy vs Gelclair: A Preliminary, Double Centre, Randomized Controlled Trial on Patients With Radiotherapy-Induced Oral Mucositis,&rdquo; <i>Support Care Cancer</i>, 2007, 15(4):427-40.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/oral-mucosal-barrier-gel-drug-information/abstract-text/17131132/pubmed\" target=\"_blank\" id=\"17131132\">17131132</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Episil [package insert]. Baltimore, MD; Cangene bioPharma Inc; July, 2012. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Gelclair [package insert]. Raleigh, NC: Dara Biosciences; December 2012. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hita-Iglesias P, Torres-Lagares D, and Guti&eacute;rrez-P&eacute;rez JL, &ldquo;Evaluation of the Clinical Behavior of a Polyvinylpyrrolidone and Sodium Hyalonurate gel (Gelclair) in Patients Subjected to Surgical Treatment With CO2 Laser,&rdquo; <i>Int J Oral Maxillofac Surg</i>, 2006, 35(6):514-7.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/oral-mucosal-barrier-gel-drug-information/abstract-text/16497479/pubmed\" target=\"_blank\" id=\"16497479\">16497479</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Mucotrol [product information]. Ripley, MS: Edwards Pharmaceuticals Inc; February 2006. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    MuGard [product information]. Waltham, MA: AMAG Pharmaceuticals Inc; December 2014.  </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Naidu MU, Ramana GV, Ratnam SV, et al, &ldquo;A Randomised, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy of MF 5232 (Mucotrol), a Concentrated Oral Gel Wafer, in the Treatment of Oral Mucositis,&rdquo; <i>Drugs R D</i>, 2005, 6(5):291-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/oral-mucosal-barrier-gel-drug-information/abstract-text/16128599/pubmed\" target=\"_blank\" id=\"16128599\">16128599</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Orafate [prescribing information]. Foster, RI: McCullough Mueller Enterprises LLC; August 2015. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    ProThelial [prescribing information]. Foster, RI: McCullough Mueller Enterprises LLC; August 2015. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Vokurka S, Skardova J, Hruskova R, et al, &ldquo;The Effect of Polyvinylpyrrolidone-Sodium Hyaluronate Gel (Gelclair) on Oral Microbial Colonization and Pain Control Compared With Other Rinsing Solutions in Patients With Oral Mucositis After Allogeneic Stem Cells Transplantation,&rdquo; <i>Med Sci Monit</i>, 2011, 17(10):CR572-6.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/oral-mucosal-barrier-gel-drug-information/abstract-text/21959611/pubmed\" target=\"_blank\" id=\"21959611\">21959611</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 9507 Version 60.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F7290545\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F7303413\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F7303465\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F46105135\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F7303466\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F7303470\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F20452770\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms Considerations\" href=\"#F46105136\" class=\"outlineLink\">Dosage Forms Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F7303467\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F7303414\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F7303418\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F7303415\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F7303416\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F16061134\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F16061132\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F7303469\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F7303563\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F23613343\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/9507|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=oral-mucosal-barrier-gel-patient-drug-information\" class=\"drug drug_patient\">Oral mucosal barrier gel: Patient drug information</a></li></ul></div></div>","javascript":null}